Shenzhen Edge Medical Co., Ltd. (HKG:2675) On The Verge Of Breaking Even
With the business potentially at an important milestone, we thought we'd take a closer look at Shenzhen Edge Medical Co., Ltd.'s (HKG:2675) future prospects. Shenzhen Edge Medical Co., Ltd. engages in designing, developing, manufacturing, and sale of surgical robots in Europe, and China. On 31 December 2025, the HK$16b market-cap company posted a loss of CN¥89m for its most recent financial year. Many investors are wondering about the rate at which Shenzhen Edge Medical will turn a profit, with the big question being “when will the company breakeven?” Below we will provide a high-level summary of the industry analysts’ expectations for the company.
According to the 4 industry analysts covering Shenzhen Edge Medical, the consensus is that breakeven is near. They anticipate the company to incur a final loss in 2025, before generating positive profits of CN¥73m in 2026. The company is therefore projected to breakeven around 12 months from now or less. At what rate will the company have to grow in order to realise the consensus estimates forecasting breakeven in under 12 months? Using a line of best fit, we calculated an average annual growth rate of 88%, which is extremely buoyant. If this rate turns out to be too aggressive, the company may become profitable much later than analysts predict.
Underlying developments driving Shenzhen Edge Medical's growth isn’t the focus of this broad overview, however, keep in mind that typically a high growth rate is not out of the ordinary, particularly when a company is in a period of investment.
View our latest analysis for Shenzhen Edge Medical
Before we wrap up, there’s one aspect worth mentioning. Shenzhen Edge Medical currently has no debt on its balance sheet, which is rare for a loss-making growth company, which typically has high debt relative to its equity. This means that the company has been operating purely on its equity investment and has no debt burden. This aspect reduces the risk around investing in the loss-making company.
Next Steps:
This article is not intended to be a comprehensive analysis on Shenzhen Edge Medical, so if you are interested in understanding the company at a deeper level, take a look at Shenzhen Edge Medical's company page on Simply Wall St. We've also compiled a list of pertinent factors you should further examine:
- Valuation: What is Shenzhen Edge Medical worth today? Has the future growth potential already been factored into the price? The intrinsic value infographic in our free research report helps visualize whether Shenzhen Edge Medical is currently mispriced by the market.
- Management Team: An experienced management team on the helm increases our confidence in the business – take a look at who sits on Shenzhen Edge Medical’s board and the CEO’s background.
- Other High-Performing Stocks: Are there other stocks that provide better prospects with proven track records? Explore our free list of these great stocks here.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.